You just read:

Bayer HealthCare to Sponsor World Federation of Hemophilia Global Training Program and Donate Kogenate® FS, Antihemophilic Factor (Recombinant), Commercially Valued At More Than $7 Million

News provided by

Bayer HealthCare Pharmaceuticals

Apr 28, 2011, 12:40 ET